1. Home
  2. GDTC vs GMM Comparison

GDTC vs GMM Comparison

Compare GDTC & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • GMM
  • Stock Information
  • Founded
  • GDTC 2018
  • GMM 2017
  • Country
  • GDTC Singapore
  • GMM China
  • Employees
  • GDTC N/A
  • GMM N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • GMM
  • Sector
  • GDTC Health Care
  • GMM
  • Exchange
  • GDTC Nasdaq
  • GMM Nasdaq
  • Market Cap
  • GDTC 23.7M
  • GMM 19.1M
  • IPO Year
  • GDTC 2023
  • GMM 2023
  • Fundamental
  • Price
  • GDTC $2.13
  • GMM $0.41
  • Analyst Decision
  • GDTC Buy
  • GMM
  • Analyst Count
  • GDTC 1
  • GMM 0
  • Target Price
  • GDTC $5.00
  • GMM N/A
  • AVG Volume (30 Days)
  • GDTC 12.4K
  • GMM 777.3K
  • Earning Date
  • GDTC 01-01-0001
  • GMM 07-23-2024
  • Dividend Yield
  • GDTC N/A
  • GMM N/A
  • EPS Growth
  • GDTC N/A
  • GMM N/A
  • EPS
  • GDTC N/A
  • GMM 0.60
  • Revenue
  • GDTC $330,254.00
  • GMM $33,985,284.00
  • Revenue This Year
  • GDTC $4.46
  • GMM N/A
  • Revenue Next Year
  • GDTC N/A
  • GMM N/A
  • P/E Ratio
  • GDTC N/A
  • GMM $0.76
  • Revenue Growth
  • GDTC N/A
  • GMM 59.78
  • 52 Week Low
  • GDTC $1.20
  • GMM $0.40
  • 52 Week High
  • GDTC $5.50
  • GMM $15.47
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 69.51
  • GMM 28.13
  • Support Level
  • GDTC $1.96
  • GMM $0.40
  • Resistance Level
  • GDTC $2.16
  • GMM $0.60
  • Average True Range (ATR)
  • GDTC 0.15
  • GMM 0.06
  • MACD
  • GDTC 0.03
  • GMM -0.02
  • Stochastic Oscillator
  • GDTC 84.07
  • GMM 2.44

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd, formerly Global Mofy Metaverse Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: